A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
for Exocrine Pancreatic Insufficiency (EPI)
9 locations incl. Scottsdale
Sponsor: Aimmune Nestlé Health Science US R&D, LLC
Sex: All·Age: 18 - 85
Code: NCT07559175·Phase 2·Not Yet Recruiting